MyMD grants 1M options to President/CMO; salary raised to $500k

Q/C TECHNOLOGIES, INC.

Options to purchase 1,000,000 shares at $0.81 per share, vesting on clinical milestones over 12 months.
Annual base salary set at $500,000 retroactive to Jan 1, 2023, under amended employment agreement.
Dr. Chapman must devote majority of efforts to the Company.
Options granted under the 2021 Equity Incentive Plan approved by compensation committee.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.